newcleo (Nasdaq: NWCL) completed its acquisition of Bonifait Pesage, bringing a French supplier of nuclear-grade weighing equipment into the company. The transaction valued Bonifait Pesage at an equity value of €1.8 million, with purchase consideration comprising cash and newcleo shares. Bonifait Pesage reported revenue of approximately €2.1 million in 2025.
The acquisition supports newcleo’s planned mixed-oxide (MOX) fuel manufacturing facilities in the United States and Europe, where weighing equipment will support tracking and control of nuclear materials. newcleo says bringing the supplier in-house reduces supply-chain exposure and provides preferred access to equipment tailored to its requirements. Bonifait Pesage will continue serving its existing customers in the wider nuclear industry.
newcleo (NWCL) inaugurated its FASTER fuel engineering, testing and training center in Chusclan, France, representing an investment of around €10 million. The non-nuclear center supports development and qualification of manufacturing processes for MOX fuel, a mixture of uranium and plutonium oxides. Seven test facilities are operational, with further installations under development. newcleo expects the center to help reduce development risks before deployment in licensed manufacturing facilities.
The company has proposed a MOX fuel fabrication facility in France’s Aube department. In July 2026, French nuclear regulator ASNR issued an overall satisfactory evaluation of its proposed safety options, ahead of a planned construction license application. FASTER also benefits from Bonifait Pesage’s expertise; newcleo’s acquisition of that company is expected to close in Q4 2026.
newcleo (NWCL) reported first-half 2026 revenue of approximately €19.4 million, up approximately 46% from the same period in 2025. Gross profit rose 48% to €6.130 million, while net loss increased approximately 10% to €81.981 million. Cash was €66.540 million at June 30; preliminary, unaudited cash was approximately €233 million at September 30.
The business combination with NewHold Investment Corp III closed September 21, generating approximately $247 million in gross proceeds. Shares and warrants began Nasdaq Global Select Market trading September 22. PRECURSOR's main vessel and turbine were installed; construction completion is expected by end-2026. French regulators gave a satisfactory evaluation of proposed MOX fuel facility safety features, and U.S. pre-application engagement plans were submitted. The Bonifait Pesage acquisition is expected to close in fourth-quarter 2026.
newcleo (NWCL) expects William D. Magwood, IV to join its Board of Directors as Vice-Chairman, effective January 1, 2027.
Magwood is Director-General of the OECD Nuclear Energy Agency and will leave that role at the end of 2026. He previously served as a U.S. Nuclear Regulatory Commission commissioner from 2010 to 2014 and led the U.S. Department of Energy’s Office of Nuclear Energy from 1998 to 2005. The company sees his regulatory and policy experience as support for its pursuit of licensing globally. His anticipated appointment follows the announcement naming Jeffrey Lyash as board chairman.
newcleo (NWCL) subsidiary Rütschi celebrated its 80th anniversary on September 25, 2026, in Illzach, France. Founded in Switzerland in 1946 and established in Alsace since 1970, the pump manufacturer has delivered more than 5,200 pumps to over 110 nuclear power plants worldwide, including all French nuclear power plants. Its equipment serves cooling, safety and effluent management functions. Rütschi also supplies spare parts and maintenance services.
Rütschi signed a 12-year framework agreement with EDF in September 2025 to manufacture pumps for future projects, including the EPR2 programme. Its Illzach site, which employs around 60 people, has a €3 million modernisation programme covering changes to its test bench and new assembly lines for EPR2 equipment and newcleo’s future reactors. Rütschi joined newcleo in 2023 and continues to serve its existing nuclear-industry customers.
newcleo (NWCL) began trading its ordinary shares and warrants on the Nasdaq Global Select Market on September 22, 2026, under the ticker symbols “NWCL” and “NWCLW”.
The company describes the Nasdaq listing as a milestone that provides capital access and a platform to accelerate deployment of its advanced modular reactor and nuclear fuel manufacturing technology in Europe and the United States. The listing is expected to support completion and operation of a 10MWth non-nuclear demonstrator in Italy, progress in regulatory and licensing interactions with U.S. and French nuclear safety regulators, and pursuit of commercial opportunities for reactors and fuel facilities in the U.S. and Europe.
newcleo (NWCL) closed its previously announced business combination with SPAC NewHold Investment Corp III (NHIC) and will begin trading on the Nasdaq Global Select Market under ticker symbols “NWCL” (ordinary shares) and “NWCLW” (warrants) on September 22, 2026.
The transaction delivers approximately $247 million in gross proceeds, including an oversubscribed $216 million PIPE and $31 million from NewHold’s trust, and values newcleo at a pre-money equity value of about $2.4 billion. Up to an additional $75 million may become available under a forward purchase agreement. Including this deal, newcleo has raised over $1 billion to date. Existing shareholders rolled over 100% of their equity, the current management team remains, and a new board chaired by industry veteran Jeffrey Lyash has been appointed.